# Vortioxetine

## BrinteLLIX 10mg (Lundbeck)

| TAH Drug Code      | [OBRIN1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OBRIN1                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of major depressive disorder (MDD).                                                                                                                                                                                                                                                                                                                                                                                |
| Dosing             | Adult <65 years old: Initial 10mg QD PO. The dose can be increased up to 20mg or decreased to 5mg based on individual response. >=65 years and older: Initial 5mg QD PO. Caution is advised when using doses exceeding 10mg daily. Treatment should continue for at least 6 months after symptom relief to consolidate the antidepressant effect. Vortioxetine is administered orally and can be taken with or without food. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Hypersensitivity to vortioxetine or any component of the formulation. Use of monoamine oxidase inhibitors (MAOIs) intended to treat psychiatric disorders (concurrently or within 21 days of discontinuing vortioxetine or within 14 days of discontinuing the MAOI). Initiation of vortioxetine in a patient receiving IV methylene blue.                                                                                   |
| Adverse Effects    | Common: Constipation (3-6%), Nausea (21-32%), Vomiting (3-6%) Serious: Hyponatremia, Hemorrhage, Hypersensitivity reaction, Sexual dysfunction (Women, 22-34%; men, 16-29%), Serotonin syndrome                                                                                                                                                                                                                              |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/vortioxetine-drug-information)                                                                                                                                                                                                                                                                                                                                                  |

